Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Depreciation & Amortization (CF) came in at $192.3 million in Q2 2026, up 26.43% year-on-year from $152.1 million in Q2 2025, and up 7.49% quarter-over-quarter from $178.9 million in Q1 2026.
Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Intuitive Surgical's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $192.3 million for Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 26.43% year-over-year to $192.3 million in Q2 2026; TTM through Jun 2026 was $696.3 million, a 32.91% increase from a year earlier, with the FY2025 full-year figure at $614.7 million, up 38.04% from the prior year.
- Depreciation & Amortization (CF) climbed to $192.3 million in Q2 2026 per ISRG's latest filing, from $178.9 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $192.3 million in Q2 2026 and bottomed at $77.7 million in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $109.8 million (2024), against an average of $120.6 million.
- Across the five-year window, Depreciation & Amortization (CF) grew 2.96% in 2024 and soared 42.42% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $98.6 million in 2022, then advanced by 19.78% to $118.1 million in 2023, then rose by 2.96% to $121.6 million in 2024, then surged by 38.49% to $168.4 million in 2025, then climbed by 14.19% to $192.3 million in 2026.
- Per Business Quant, the three latest ISRG Depreciation & Amortization (CF) figures stand at $192.3 million (Q2 2026), $178.9 million (Q1 2026), and $168.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 237.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192.30 Mn |
| Jun 30, 2026 | 192.30 Mn |
| Mar 31, 2026 | 178.90 Mn |
| Mar 31, 2026 | 178.90 Mn |
| Dec 31, 2025 | 168.40 Mn |
| Dec 31, 2025 | 168.40 Mn |
| Sep 30, 2025 | 156.70 Mn |
| Sep 30, 2025 | 156.70 Mn |
| Jun 30, 2025 | 152.10 Mn |
| Jun 30, 2025 | 152.10 Mn |
| Mar 31, 2025 | 137.50 Mn |
| Mar 31, 2025 | 137.50 Mn |
| Dec 31, 2024 | 121.60 Mn |
| Dec 31, 2024 | 121.60 Mn |
| Sep 30, 2024 | 112.70 Mn |
| Sep 30, 2024 | 112.70 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Mar 31, 2024 | 104.20 Mn |
| Mar 31, 2024 | 104.20 Mn |